Further re Rule 2.11d disclosure
10 Dezembro 2010 - 12:26PM
UK Regulatory
TIDMBII TIDMBGC
Disclosure under Rule 2.11d of The Takeover Code
Aberforth Partners LLP ("Aberforth") provided a non-binding letter of intent to
BTG plc regarding BTG plc's proposed acquisition of Biocompatibles
International plc ("Biocompatibles"), as referred to in the announcement of the
acquisition dated 19 November 2010. On 09 December 2010, Aberforth disposed of
40,057 shares (over which it had voting authority) in Biocompatibles, on behalf
of clients. As a result, Aberforth now intends to vote in favour of the
resolutions to be proposed at the Court Meeting and the Biocompatibles general
meeting necessary to approve the Scheme (or as the case may be, to accept the
Takeover Offer) in respect of 3,676,082 Biocompatibles shares, over which it
has voting authority.
Date: 10 December 2010
Contact: Pauline Robson, for Aberforth Partners LLP
Telephone: 0131 220 0733
END
Biocompatibles (LSE:BII)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Biocompatibles (LSE:BII)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024
Notícias em tempo-real sobre Biocompatibles da Bolsa de Valores de Londres bolsa de valores: 0 artigos recentes
Mais Notícias de Biocompatibles